about
Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.Using galectin-3 to reduce heart failure rehospitalization.Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Galectin-3 and new-onset CKD: marker or mediator?
@en
Galectin-3 and new-onset CKD: marker or mediator?
@nl
type
label
Galectin-3 and new-onset CKD: marker or mediator?
@en
Galectin-3 and new-onset CKD: marker or mediator?
@nl
prefLabel
Galectin-3 and new-onset CKD: marker or mediator?
@en
Galectin-3 and new-onset CKD: marker or mediator?
@nl
P2860
P356
P1476
Galectin-3 and new-onset CKD: marker or mediator?
@en
P2093
Brendan J Barrett
Pietro Ravani
P2860
P304
P356
10.1681/ASN.2013050552
P577
2013-06-20T00:00:00Z